4-(Trifluoromethyl)thiazole-2-carboximidamide hydrochloride

Catalog No. :
ACMDVI623
CAS No. :
1251166-15-0
Molecular Formula :
C5H5ClF3N3S
Molecular Weight :
231.63

IUPAC Name:4-(trifluoromethyl)thiazole-2-carboximidamide hydrochloride

4-(Trifluoromethyl)thiazole-2-carboximidamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$494.00Login to see priceInquiryInquiry
250mg97%$696.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Trifluoromethyl)thiazole-2-carboximidamide hydrochloride
IUPAC Name4-(trifluoromethyl)thiazole-2-carboximidamide hydrochloride
MDL No.MFCD21605322
Molecular FormulaC5H5ClF3N3S
Molecular Weight231.63
SMILESN=C(C1=NC(C(F)(F)F)=CS1)N.[H]Cl
InChI KeySRJWJSDIRPGAJK-UHFFFAOYSA-N
Synonym4-(Trifluoromethyl)thiazole-2-carboximidamide hydrochloride
CAS No.1251166-15-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACMDVI623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPUEC607 route compound structure diagram
    ACPUEC6071221188-44-8 In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACMDVI623 route product structure diagram
    ACMDVI6231251166-15-0
Inquiry

2. ACMDVI623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOEQL201 route compound structure diagram
    ACOEQL20141731-39-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACIJHZ241 route compound structure diagram
    ACIJHZ24169267-75-0 In Stock
  6. Then
  7. ACMDVI623 route product structure diagram
    ACMDVI6231251166-15-0
Inquiry

Comments (0)